Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
…, E Gordon, A Fellows, J Toombs, R Druyeh… - Neurology, 2016 - AAN Enterprises
Objective: To investigate serum neurofilament light chain (NfL) concentrations in frontotemporal
dementia (FTD) and to see whether they are associated with the severity of disease. …
dementia (FTD) and to see whether they are associated with the severity of disease. …
Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration
Objectives: To investigate whether serum neurofilament light (NfL) concentration is increased
in familial Alzheimer disease (FAD), both pre and post symptom onset, and whether it is …
in familial Alzheimer disease (FAD), both pre and post symptom onset, and whether it is …
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease
…, A Heslegrave, NS Ryan, Y Liang, R Druyeh… - Alzheimer's research & …, 2019 - Springer
Background To investigate how serum neurofilament light (NfL) concentration changes
through the course of disease in familial Alzheimer’s disease (FAD) and to assess when NfL …
through the course of disease in familial Alzheimer’s disease (FAD) and to assess when NfL …
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
AGB Thompson, P Anastasiadis, R Druyeh… - Molecular …, 2021 - nature.com
Prion diseases are fatal neurodegenerative conditions with highly accurate CSF and imaging
diagnostic tests, but major unmet needs for blood biomarkers. Using ultrasensitive immuno-…
diagnostic tests, but major unmet needs for blood biomarkers. Using ultrasensitive immuno-…
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years
…, J Lowe, P Norsworthy, H Hummerich, R Druyeh… - Brain, 2015 - academic.oup.com
Patients with iatrogenic Creutzfeldt-Jakob disease due to administration of cadaver-sourced
growth hormone during childhood are still being seen in the UK 30 years after cessation of …
growth hormone during childhood are still being seen in the UK 30 years after cessation of …
R47H TREM2 variant increases risk of typical early‐onset Alzheimer's disease but not of prion or frontotemporal dementia
…, Z Abdi, J Uphill, T Campbell, R Druyeh… - Alzheimer's & …, 2014 - Wiley Online Library
Background Rare TREM2 variants are significant risk factors for Alzheimer's disease (AD).
Methods We used next generation sequencing of the whole gene (n = 700), exon 2 Sanger …
Methods We used next generation sequencing of the whole gene (n = 700), exon 2 Sanger …
[HTML][HTML] ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology
Introduction Apolipoprotein E (ApoE) is the most important genetic risk factor for Alzheimer's
disease (AD), with ApoE4 thought to enhance and accelerate amyloid-β (Aβ) pathology. …
disease (AD), with ApoE4 thought to enhance and accelerate amyloid-β (Aβ) pathology. …
Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob disease
…, N Bjurstrom, E Franko, M Gorham, R Druyeh… - JAMA …, 2016 - jamanetwork.com
Importance A major challenge for drug development in neurodegenerative diseases is that
adequately powered efficacy studies with meaningful end points typically require several …
adequately powered efficacy studies with meaningful end points typically require several …
Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series
C Koriath, J Kenny, G Adamson, R Druyeh… - Molecular …, 2020 - nature.com
Next-generation genetic sequencing (NGS) technologies facilitate the screening of multiple
genes linked to neurodegenerative dementia, but there are few reports about their use in …
genes linked to neurodegenerative dementia, but there are few reports about their use in …
[HTML][HTML] A small deletion in C9orf72 hides a proportion of expansion carriers in FTLD
…, JB Callister, K Young, SJ Ryan, R Druyeh… - Neurobiology of …, 2015 - Elsevier
Frontotemporal lobar degeneration is a highly familial disease and the most common known
genetic cause is the repeat expansion mutation in the gene C9orf72. We have identified 2 …
genetic cause is the repeat expansion mutation in the gene C9orf72. We have identified 2 …
